U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically ...

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.